Last $25.54 USD
Change Today +0.06 / 0.24%
Volume 185.0K
CMRX On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Earl R. Kern Ph.D.

Member of Scientific Advisory Board, Chimerix, Inc.
AgeTotal Calculated CompensationThis person is connected to 14 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Earl R. Kern Ph.D. serves as Professor in the department of pediatrics, division of clinical virology. Dr. Kern serves as senior scientist at the University of Alabama comprehensive cancer center and the center for AIDS research. Dr. Kern also holds secondary appointments in the department of comparative medicine and the department of microbiology. His areas of interest span chemotheraphy and pathogenesis of viral infections in animal models, preclinical evaluation of ...

Read Full Background

Corporate Headquarters*

2505 Meridian Parkway
Durham, North Carolina 27713

United States

Phone: 919-806-1074
Fax: 919-806-1146

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MS
The University of Utah
PhD
The University of Utah
BS
The University of Utah

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CMRX:US $25.54 USD +0.06

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Eric A. Rose M.D.Executive Chairman, Chief Executive Officer and Member of National Biodefense Science Board
SIGA Technologies, Inc.
$1.1M
Paul Chaplin MSc, Ph.D.Chief Executive Officer and President
Bavarian Nordic A/S
--
Peter Mørch Eriksen BBAChief Executive Officer and Administration Director
BioPorto A/S
--
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director and Member of Strategic Operations Committee
Emergent BioSolutions, Inc.
$1.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHIMERIX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.